Clinical trials
Completed Phase 1/2 Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 3 |
| Santen Inc. | 2 |
| Acuity Medical International, Inc. | 1 |
| Allegro Ophthalmics, LLC | 1 |
| Allergan | 1 |
| Astellas Institute for Regenerative Medicine | 1 |
| California Retina Consultants | 1 |
| Chengdu Kanghong Biotech Co., Ltd. | 1 |
| EyeBiotech Ltd. | 1 |
| Federal University of São Paulo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 40 |
| Choroidal Neovascularization | 5 |
| Geographic Atrophy | 4 |
| Retinal Diseases | 4 |
| Eye Diseases | 2 |
| Glycogen Storage Disease Type II | 2 |
| Macular Edema | 2 |
| Retinal Vein Occlusion | 2 |
| Stargardt Disease | 2 |
| Wet Macular Degeneration | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.